Enteric fever in Cambodian children is dominated by multidrug-resistant H58 Salmonella enterica serovar Typhi with intermediate susceptibility to ciprofloxacin  by Emary, Kate et al.
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Infections  with  Salmonella  enterica  serovar  Typhi  isolates  that  are  multidrug  resistant  (MDR:
resistant  to  chloramphenicol,  ampicillin,  trimethoprim–sulphamethoxazole)  with  interme-
diate ciproﬂoxacin  susceptibility  are  widespread  in  Asia  but there  is  little  information  from
Cambodia.  We  studied  invasive  salmonellosis  in  children  at a paediatric  hospital  in  Siem
Reap,  Cambodia.  Between  2007  and  2011  Salmonella  was  isolated  from  a  blood  culture
in 162  children.  There  were  151  children  with  enteric  fever,  including  148  serovar  Typhi
and three  serovar  Paratyphi  A  infections,  and  11  children  with  a  non-typhoidal  Salmonella
infection.  Of  the  148  serovar  Typhi  isolates  126  (85%)  were  MDR  and  133  (90%)  had  interme-
diate ciproﬂoxacin  susceptibility.  Inpatient  antimicrobial  treatment  was  ceftriaxone  alone
or initial  ceftriaxone  followed  by a step-down  to oral  ciproﬂoxacin  or  azithromycin.  Com-
plications  developed  in  37/128  (29%)  children  admitted  with  enteric  fever  and  two  (1.6%)
died. There  was  one  conﬁrmed  relapse.  In a  sample  of  102  serovar  Typhi  strains  genotyped
by investigation  of a  subset  of single  nucleotide  polymorphisms,  98  (96%)  were  the  H58
haplotype,  the  majority  of  which  had  the common  serine  to phenylalanine  substitution
at  codon  83  in  the  DNA gyrase.  We  conclude  that antimicrobial-resistant  enteric  fever  is
common  in  Cambodian  children  and  therapeutic  options  are  limited.
© 2012 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd.∗ Corresponding author. Present address: Mahidol–Oxford Tropical
edicine Research Unit, Faculty of Tropical Medicine, Mahidol University,
angkok, Thailand. Tel.: +66 02 203 6333; fax: +66 02 354 9169.
E-mail address: chrisp@tropmedres.ac (C.M. Parry).
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1. Introduction
Invasive bacterial infections are a signiﬁcant cause
of morbidity and mortality among children in southeast
Asia.1,2 Members of the genus Salmonella,  including the
enteric fever serovars Typhi and Paratyphi A, and various
non-typhoidal serovars are commonly isolated from the
ygiene. Published by Elsevier Ltd. All rights reserved.
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blood of febrile children in resource-limited settings.3–5
Isolates of serovar Typhi and Paratyphi A resistant to mul-
tiple antimicrobial agents have caused epidemics and are
endemic in many areas of southeast and south Asia.6
These include multidrug-resistant (MDR) isolates resistant
to the previous ﬁrst-line antimicrobials (chloramphenicol,
ampicillin, co-trimoxazole) and those with intermedi-
ate susceptibility to ciproﬂoxacin (previously described
as decreased ciproﬂoxacin susceptibility).7,8 Antimicrobial
resistance has restricted the treatment choice for enteric
fever and other invasive salmonellosis.6
In 2010 the under-ﬁve year mortality rate in the
Kingdom of Cambodia was 54/1000 live births and the
prevalence of malnutrition (below 2 SD of weight for age)
was 28%.9 There is little published information concern-
ing invasive bacterial infections in Cambodian children,
including typhoid fever, partly as a consequence of the lack
of functional microbiology laboratories.2 In a prospective
community study conducted between 2006 and 2009 in
children and adults with fever in two districts within 50 km
of the capital, Phnom Penh, of almost 5000 blood cultures,
S. enterica Typhi was isolated in 41 (0.9%).10 Of these 41
serovar Typhi isolates, 23 (56%) were MDR  and 36 (88%)
had intermediate susceptibility to ciproﬂoxacin.
At Angkor Hospital for Children (AHC), in Siem Reap
province in northwest Cambodia, a microbiology labo-
ratory with the capacity to perform blood cultures was
established in 2006. Since April 2010 the laboratory has
also received blood cultures from a satellite clinic and
ward in Sotr Nikom District, 30 km away. A small study
at AHC conducted in 2009 suggested that antimicrobial-
resistant enteric fever could be an important problem at
this location.11 Here we report a retrospective analysis of
the demographic, epidemiological and clinical characteris-
tics of children at these hospitals with Salmonella-positive
blood cultures, between 2007 and 2011.
2. Materials and methods
2.1. Study population
The study was conducted at AHC and the AHC Satel-
lite Clinic (SC) in Sotr Nikom District, Siem Reap Province,
Cambodia. The two facilities are charity funded and
provide free outpatient, inpatient, emergency, surgical,
medical, ophthalmological and dental care. There are
50 inpatient beds at AHC and 20 at SC and the two out-
patient departments see more than 400 children each day
from an unrestricted catchment area, with the majority of
patients from Siem Reap or neighbouring provinces.
This was a retrospective cross-sectional study of chil-
dren from whom Salmonella was isolated from a blood
culture between 1 January 2007 and 31 December 2011
inclusive. Children were identiﬁed by inspection of the
laboratory register. A retrospective review of case records
of identiﬁed children was performed to collect data on
age, gender, clinical features, antimicrobial therapy (type,
route and duration), infection-associated complications,
duration of hospital stay and outcome at hospital dis-
charge, all of which were documented on a standard
case report form. Epi Info V.3.5.3 (CDC, Atlanta, GA, USA)ical Medicine and Hygiene 106 (2012) 718– 724 719
was used to calculate the weight for age z scores using
CDC Clinical Growth Charts for the United States (2000)
(http://www.cdc.gov/growthcharts/).
2.2. Microbiological methods
Blood cultures in children with fever or suspected sep-
sis were performed at the discretion of the clinicians. Blood
for culture (generally between 1 and 2 ml)  was  collected
by a member of the laboratory staff and inoculated into
a bottle containing 20 ml  Tryptic Soy Broth with added
sodium polyethanolsuphonate (all media from Oxoid,
Basingstoke, Hampshire, UK). The bottles were incubated
at 35–37 ◦C and inspected daily. If the broth was cloudy a
Gram stain was  performed and the broth inoculated onto
sheep blood agar, chocolate agar and MacConkey agar. Oth-
erwise a blind subculture was  performed onto sheep blood
and chocolate agar after 24 h, 48 h and 7 days of incuba-
tion. Gram-negative bacilli were identiﬁed by biochemical
testing (triple sugar iron agar, motility, lysine decar-
boxylase, indole production, citrate and urea utilization)
or API 20E (bioMérieux, Marcy l’Etoile, France). Putative
S. enterica isolates were conﬁrmed by agglutination with
speciﬁc antisera (Bio-Rad, Hemel Hempstead, Hertford-
shire, UK).
Antimicrobial susceptibilities were performed at
the time of isolation by a modiﬁed Bauer-Kirby disc
diffusion method, inhibition zone sizes were recorded
and interpretations of the zone sizes were based on
the latest CLSI guidelines.12 The antimicrobials tested
(Oxoid) were chloramphenicol (30 g), ampicillin (10 g),
trimethoprim–sulphamethoxazole (1.25/23.75 g), cef-
triaxone (30 g), ciproﬂoxacin (5 g), azithromycin
(15 g) and nalidixic acid (30 g). Isolates were stored in
Tryptic Soy Broth with 20% glycerol at −80 ◦C.
A representative selection of 102 stored S. enterica
Typhi isolates were later subcultured and the min-
imum inhibitory concentration (MIC) determined by
E-test strips according to the manufacturer’s guidelines
(AB Biodisk, Solna, Sweden). The evaluated antimicro-
bials were ciproﬂoxacin, gatiﬂoxacin, ceftriaxone and
azithromycin. Escherichia coli ATCC 25922 and Staphy-
lococcus aureus ATCC 25923 were used as control
strains for these assays. An isolate was  deﬁned as
MDR  if it was  resistant to all of the following: chlor-
amphenicol (≥32 g/ml), ampicillin (≥32 g/ml) and
trimethoprim/sulfamethoxazole (≥8/152 g/ml). Interme-
diate susceptibility to ciproﬂoxacin (formerly known as
decreased ciproﬂoxacin susceptibility) was deﬁned by
an MIC  of 0.12–0.5 g/ml and resistance by an MIC  of
≥1 g/ml.12 The equivalent values for gatiﬂoxacin were
4 g/ml and ≥8 g/ml and for ceftriaxone 2 g/ml and
≥4 g/ml. There are no recommended CLSI breakpoints for
azithromycin against Salmonella.
2.3. Molecular typingWe  sought to distinguish the H58 serovar Typhi
strains, as these are the most common and ubiquitous
across Asia, from non-H58 strains by inferring genotype
though the detection of the H58-speciﬁc single nucleotide
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olymorphism (SNP) using a modiﬁed pyrosequencing
echnique. Salmonella Typhi belong to haplotype H58 if the
NP at nucleotide 252 on the gene glpA (corresponds to
TY2513 from GenBank accession no. AL513382, Salmonella
yphi CT18) is T, otherwise they belong to non-H58.13
he common SNPs inducing intermediate susceptibility to
iproﬂoxacin, located at position 83 and 87 in the gyrA gene
nd position 80 in the parC gene, were also determined by
odiﬁed pyrosequencing.7
Genomic DNA was prepared from the bacterial iso-
ates using the Wizard genomic DNA puriﬁcation kit
Promega, Madison, WI,  USA). The prepared DNA was
CR ampliﬁed using the following primer pairs target-
ng the regions containing the H58 SNP: forward primer
′biotin GTAACGTCAGCCGCGGTATT; reverse primer 5′
CCATCAGGCGATAAGTCATTA 3′. SNPs in the gyrA gene
codons 83 and 87) and a SNP in the parC (codon 80) gene
ere ampliﬁed and sequenced using the following primers:
yrA codon 83: F 5′ TGGGCAATGACTGGAACAAAG 3′, R
′biotin TACCGTCATAGTTATCCACG 3′, Seq 5′ CGGTAAAT-
CCATCCCCA 3′; gyrA codon 87: F 5′ TGGGCAATGACTG-
AACAAAG 3′, R 5′ biotin TACCGTCATAGTTATCCACG 3′, Seq
′ CGATTCCGCAGTGTA 3′; and parC codon80: F 5′ biotin
CCGTTGGCGACGTACTGG 3′, R 5′ AATTCCCCTGGCCATC-
AC 3′, Seq 5′ CATGGCTTCATAGCAG 3′.
All PCR ampliﬁcations were performed in 60 l reac-
ions containing 1 × NH4 buffer, 1.5 mM of MgCl2, 200 M
f dNTP, 10 pM of each primer, 1.25 units of Hotstart DNA
olymerase (Qiagen, Valencia, CA, USA) and 5 l of tem-
late DNA. Reactions were cycled once at 95 ◦C for 15 min,
ollowed by 30 cycles of 94 ◦C for 1 min, 55 ◦C for 1 min  and
2 ◦C for 1 min, with a ﬁnal elongation of 72 ◦C for 5 min. All
CR ampliﬁcations were observed on 1% agarose gels prior
o pyrosequencing to ensure correct ampliﬁcation. We  used
 pyrosequencer (Pyromark Q96 ID DNA pyrosequencer,
able 1
linical features of Cambodian children admitted to hospital with culture-conﬁrm
007  and 2011
Cases wit
Median (IQR) age (years) 7.0 (4.5–1
Male  gender 63 (49) 
Weight for age z score <−3 49/126 (3
Median (IQR) prior duration of illness (days) 6 (5–10) 
Chills 42 (33) 
Headache 54 (42) 
Cough 37 (29) 
Vomiting 73 (57) 
Diarrhoea 46 (36) 
Constipation 17 (13) 
Abdominal pain 103 (80) 
Underlying disease 7 (5) 
Hepatomegaly 70 (55) 
Splenomegaly 11 (9) 
Abdominal distension 31 (24) 
Abnormal mental state 27 (21) 
Peak  temperature ≥40.0 ◦C 68/126 (5
Median (IQR) haemoglobin (g/dl) 9.3 (7.5–1
Anaemia (<7 g/dl) 73/125 (5
Median (IQR) white cell count 7.1 (5.3–9
Median (IQR) neutrophil count 4.3 (2.8–6
Median (IQR) lymphocyte count 2.0 (1.2–2
Median (IQR) platelet count 213 (142–
ata are number (%), unless otherwise indicated.ical Medicine and Hygiene 106 (2012) 718– 724
Biotage, Uppsala, Sweden) to detect the SNP in each of the
loci sequenced. PCR amplicons were combined with 56 l
of binding buffer and 4 l of streptavidin sepharose beads.
The resulting mixture was vigorously agitated for 5 min
before being denatured in denaturation buffer and washed
using the Vacuum Prep Tool (Biotage). The single stranded
DNA fragments were transferred into a 96-well plate con-
taining 3.5 pmol of sequencing primer in 40 l of annealing
buffer and the DNA sequencing reaction was performed
using the Pyro Gold Kit (Qiagen).
2.4. Analysis
Analysis of demographic and clinical data was  descrip-
tive with continuous variables described by a median and
IQR and compared by the Mann–Whitney U test. Propor-
tions were compared using the 2 test or Fisher’s exact test.
Analysis including multivariate analysis of factors associ-
ated with complicated disease was  performed using Epi
Info (CDC) and SPSS V.18.0 (SPSS Inc., Chicago, IL, USA).
3. Results
3.1. Patients
During the 5-year study, Salmonella was  isolated from
the blood of febrile children on 162 occasions. One hun-
dred and ﬁfty-one children had enteric fever (148 with
serovar Typhi and 3 with serovar Paratyphi A), of whom
128 (85%) were hospitalised and 24 (15%) were man-
aged as outpatients. Eleven children had a non-typhoidal
Salmonella (NTS) serovar isolated from the blood culture,
10 (91%) of these were hospitalised and one (9%) was man-
aged as an outpatient.
ed enteric fever or invasive non-typhoidal salmonellosis (NTS) between
h enteric fever (n=128) Cases with NTS (n=10)
0.4) 0.9 (0.3–2.9)
7 (70)
9) 4/8 (50)
5 (3–7)
0
0
4 (40)
6 (60)
7 (70)
0
0
5 (50)
3 (30)
0
1 (10)
3 (30)
4) 0/8
0.8) 9.8 (6.8–11.1)
8) 6/9 (67)
.6) 14.5 (10.0–28.3)
.1) 7.2 (4.0–15.8)
.9) 6.1 (3.6–6.9)
311) 412 (125–677)
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3.2. Clinical features
The clinical features of the hospitalised children with
invasive Salmonella are shown in Table 1 and the age dis-
tribution of the hospitalised children is shown in Figure 1.
The median (IQR, range) age of the children with enteric
fever was 7.6 years (4.9–11.2 years, 8 months–16 years),
38/151 (25.2%) were under the age of 5 years and 71/151
(47%) were male. The median (IQR, range) age of the chil-
dren with NTS was 1 year (5 months–6.9 years, 1 month–12
years), 8/11 (73%) were under the age of 5 years and 8/11
(73%) were male. Five (45%) of the 11 NTS-infected chil-
dren were known to be HIV seropositive (one under 1
year) and a further ﬁve (45%) were less than 1 year in age
with bacteraemia secondary to diarrhoea. For the children
with a weight recorded, 60/158 (38%) were malnourished,
with a weight-for-age z score of ≤3, and 87/154 (56%) chil-
dren with haemoglobin level available had a level below
10 g/dl.
3.3. Antimicrobial susceptibility patterns
Eighty-ﬁve percent (126/148) of serovar Typhi isolates
were MDR, 90% (133/148) had intermediate susceptibil-
ity to ciproﬂoxacin and 80% (119/148) were both MDR
with intermediate susceptibility to ciproﬂoxacin. There
was no signiﬁcant variation in the proportion of strains
that were MDR  or with intermediate susceptibility to
ciproﬂoxacin over the 5-year study period. None of the
isolates were resistant to ciproﬂoxacin and all were sus-
ceptible to ceftriaxone. None of the three serovar Paratyphi
Table 2
Minimum inhibitory concentrations of Salmonella enterica Typhi isolates from blo
method (n=102)
Antimicrobial MIC50 (g/ml) MIC90 (g/ml) 
Ciproﬂoxacin 0.380 0.500 
Gatiﬂoxacin 0.190 0.250 
Ceftriaxone 0.090 0.125 
Azithromycin 12 16 
MIC50 and MIC90: minimum inhibitory concentration of the antimicrobial requireears)
ic fever or non-typhoidal salmonellosis between 2007 and 2011.
A isolates were MDR  but all had intermediate susceptibility
to ciproﬂoxacin and 2/11 (18.2%) of the NTS isolates were
MDR  with 4/11 (36.4%) with intermediate susceptibility to
ciproﬂoxacin.
MICs were determined for a representative sample of
102 serovar Typhi isolates (Table 2) and the genotype was
used to infer haplotype and mutations in the gyrA and
parC loci. Ninety-six percent (98/102) of the genotyped
serovar Typhi isolates were haplotype H58. Furthermore,
the majority of H58 isolates were accompanied by a sin-
gle mutation or multiple mutations in the gyrA gene.
The majority, 93, exhibited the most described mutation,
encoding an amino acid substitution from serine to phen-
ylalanine at codon position 83 (S83F) in the DNA gyrase
protein. Three isolates containing the S83F substitution
were also accompanied by a mutation inducing a change
from aspartic acid to glycine at position 87 (D87G), one
isolate had a single substitution of aspartic acid to tyro-
sine at position 87 (D87Y) and three exhibited no mutations
in gyrA. The remaining four serovar Typhi isolates did not
belong to the H58 haplotype, and had no mutations in
the gyrA gene and were susceptible to ciproﬂoxacin. The
three serovar Paratyphi A isolates all had an aspartic acid
to asparagine gyrase A substitution at position 87 (D87N).
3.4. Clinical course and outcomeVarious antimicrobial regimens were used for the chil-
dren admitted to hospital with enteric fever (Table 3),
with most children (126/128; 98%) initially treated
with ceftriaxone. Ceftriaxone monotherapy was given to
od in Cambodian children against four antimicrobials by the E-test strip
Minimum (g/ml) Maximum (g/ml)
0.006 0.500
0.008 0.380
0.006 0.190
6 16
d to inhibit 50% and 90% of the tested isolates, respectively.
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Table  3
Response to treatment according to antimicrobial regimen given in 128 Cambodian children admitted to hospital with enteric fever
Antimicrobial regimen No. of
children
Median (IQR) duration
of antimicrobial given
(days)
Median (IQR)
fever clearance
time (days)
No. (%) with fever
clearance >7 days
No. (%) with
complication
Ceftriaxone 58 10 (7–14) 7.7 (4.0–10.8) 23 (47) 22 (38)
Ceftriaxone then ciproﬂoxacin 25 14 (12–17) 6.4 (4.3–11.2) 9 (36) 2 (8)
Ceftriaxone then azithromycin 42 13 (11–16) 4.4 (3.4–6.3) 9 (21) 12 (29)
9 1 (100) 1 (100)
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Figure 2. Kaplan–Meier plot of the proportion of inpatient children
remaining febrile after commencing therapy with: i.v. ceftriaxone
T
C
(
DCeftriaxone then ceﬁxime 1 17 
Azithromycin 2 7 and 15 
8 patients, with a step-down in 25, 42 and one patient
o oral ciproﬂoxacin, azithromycin or ceﬁxime, respec-
ively. The median duration of antimicrobial therapy varied
etween 10 and 14 days. The median fever clearance time
as 7.7 days with ceftriaxone monotherapy given for a
edian of 10 days. In the early period of the study, ceftria-
one was followed by a step-down to oral ciproﬂoxacin for
 median of 14 days; the median fever clearance time was
.4 days. When isolates with intermediate susceptibility to
iproﬂoxacin were known to be prevalent, the regimen was
mended and initial ceftriaxone was followed by a step-
own to oral azithromycin for a median of 13 days. With
his regimen the median fever clearance time was 4.4 days,
igniﬁcantly shorter than with ceftriaxone alone (log-rank
est p=0.008; Figure 2).
We  hypothesised that the protracted recovery among
hildren treated with ceftriaxone monotherapy was related
o disease severity. The complication rate in children
reated with ceftriaxone alone was 38% (22/58), com-
ared with 8% (2/25) among those treated with ceftriaxone
ollowed by ciproﬂoxacin (p=0.013) and 29% (12/42) in chil-
ren treated with ceftriaxone followed by azithromycin
p=0.45). When stratiﬁed for presence of complicated
isease, the fever clearance time remained signiﬁcantly
horter for the children treated with ceftriaxone followed
y azithromycin compared with ceftriaxone alone (log-
ank p=0.013).
A total of 37/128 (29%) and 4/10 (40%) of the hospitalised
hildren with enteric fever and NTS infection developed
 complication, respectively (p=0.48). The most common
nteric fever complication was gastrointestinal bleeding
Table 4). One child with severe abdominal pain underwent
able 4
omplications in Cambodian children admitted to hospital with culture-conﬁrm
n=10) between 2007 and 2011
Enteric fever
cases age
<5 years (n=36)
Enteric fever
cases age
5–9 years (n=56)
Complicated disease 10 (28) 20 (36) 
Gastrointestinal bleeding 4 (11) 8 (14) 
Blood  transfusion 1 (3) 6 (11) 
Jaundice 2 (6) 5 (9) 
Lung  infection 5 (14) 3 (5) 
Cholecystitis 0 5 (9) 
Haemodynamic shock 1 (3) 2 (4) 
Encephalopathy 1 (3) 1 (2) 
Surgery 0 2 (4) 
Relapse 0 1 (2) 
Death  0 2 (4) 
ata are number (%).throughout treatment for a total median duration of 10 days; or i.v. cef-
triaxone followed by a step-down to oral azithromycin for a total median
duration of 13 days.
a laparotomy, an ileus and swollen gall bladder was found,
serovar Typhi was  isolated from the gall bladder, but no
intestinal perforation was  detected. The overall case fatal-
ity rate was  2/10 (20%) in children admitted with NTS bac-
teraemia compared with 2/128 (1.6%) of children admitted
ed enteric fever (n=128) or invasive non-typhoidal salmonellosis (NTS)
Enteric fever
cases age
10–15 years (n=36)
All cases with
enteric fever
(n=128)
All cases with
NTS (n=10)
7 (19.4) 37 (29) 4 (40)
2 (6) 14 (11) 0
3 (8) 10 (8) 0
2 (6) 9 (7) 0
1 (3) 9 (7) 1 (10)
1 (3) 6 (5) 0
0 3 (2) 2 (20)
1 (3) 3 (2) 0
0 2 (2) 0
1 (2) 1 (1) 1 (10)
0 2 (2) 2 (20)
 of TropK. Emary et al. / Transactions of the Royal Society
with enteric fever (OR 15.8, 95% CI 1.0–231; p=0.03). A 6-
year-old child with enteric fever died within 24 h of admis-
sion in septic shock and a second child aged 8 years died
after 16 days of admission and ceftriaxone treatment with
a large pleural effusion and probable pneumonia. The two
children with NTS bacteraemia died within 24 h of admis-
sion with septic shock, one was aged 12 years with underly-
ing HIV infection and was one aged 1 month with diarrhoea.
Signiﬁcant factors associated with complicated disease
after univariate analysis were hepatomegaly (p<0.001),
haemoglobin <10 mg/dl (p=0.014), MDR  phenotype
(p=0.013) and intermediate susceptibility to ciproﬂoxacin
(p=0.019). After logistic regression for these multiple
factors, the presence of hepatomegaly remained indepen-
dently associated with severe disease (adjusted OR 4.8,
95% CI 3.7–4.9; p=0.004).
4. Discussion
We have described a signiﬁcant burden of
antimicrobial-resistant enteric fever in Cambodian
children. Serovar Typhi was the commonest isolate from
blood cultures in children at this location for the last
5 years and the majority were MDR  with intermediate
susceptibility to ciproﬂoxacin. These observations are in
keeping with a large community-based study near the cap-
ital Phnom Penh and suggest that drug-resistant serovar
Typhi is widespread in the country.10 Our genotyping
further demonstrated that the majority of isolates were
of the H58 haplotype, occurring concurrently with a gyrA
mutation inducing a serine to phenylalanine substitution
at position 83, a haplotype/phenotype combination, which
has become dominant in Asia and some parts of Africa in
recent years.7,13,14
The presence of MDR  strains with intermediate sus-
ceptibility to ciproﬂoxacin limits the choice of enteric
fever treatment, with ceftriaxone, azithromycin and gat-
iﬂoxacin as potential options.15–17 Ceftriaxone was used as
the initial empiric therapy for children admitted to hos-
pital as it is suitable for enteric fever and other common
invasive bacterial infections. In many cases after the diag-
nosis was conﬁrmed and the child’s condition improved,
this was changed to an oral drug. Although antimicrobial
resistance to ceftriaxone is rare in invasive Salmonellae, the
response to treatment is often slow.6 The median fever
clearance time in this study was 7.7 days with ceftriaxone
monotherapy given for 10 days. In some patients a step-
down to oral ciproﬂoxacin was employed with median
fever clearance times of 6.6 days. When it was under-
stood that most strains had intermediate susceptibility to
ciproﬂoxacin, oral ciproﬂoxacin was substituted with oral
azithromycin, and when given for 13 days the median fever
clearance time was 4.4 days. Our data, whilst uncontrolled,
suggests that in children with fever requiring hospital
admission, subsequently conﬁrmed as enteric fever, cef-
triaxone followed by a step-down to oral azithromycin is
a suitable regimen although the optimum time to step-
down requires further investigation. Gatiﬂoxacin has been
shown to be an acceptable alternative in other areas of
high DCS prevalence17 as it is less inhibited by the commonical Medicine and Hygiene 106 (2012) 718– 724 723
mutations of the gyrA gene than the older ﬂuoroquinolones,
but it is not easily available locally.
Signiﬁcantly, none of the isolates were fully resis-
tant to ciproﬂoxacin or ceftriaxone which is an emerging
problem in some areas.18,19 This is despite high rates of
extended-spectrum -lactamase carriage in other Enter-
obacteriacae circulating in children in this area.2 MDR
serovar Typhi strains were present in Cambodia in the mid-
1990s (C.M. Parry, personal observation) and appear not to
have declined as has been described in other parts of Asia.5
Molecular genotyping of the strains in this study further
demonstrates the dominance of the H58 haplotype with a
gyrA mutation leading to a S83F amino acid substitution.
This strain is also dominant in the Mekong delta in Viet-
nam and other areas of Asia and is frequently associated
with an IncHI1 plasmid carrying the genes for the MDR
phenotype,13,20,21 yet the factors that have led to the suc-
cess of this particular strain are not yet known. The MICs
against ciproﬂoxacin were in the range expected for iso-
lates with intermediate susceptibility to ciproﬂoxacin and
the values for azithromycin and gatiﬂoxacin were compa-
rable to other studies.16,17
The reported severity of enteric fever in young children
is variable across different studies.22 Some investigators
describe a mild disease with few complications23 whereas
other series describe high rates of complications and mor-
tality, particularly in the very young.24–26 Anaemia and
drug resistance, but not hepatomegaly, have been asso-
ciated with disease severity in previous studies24–26 In
this study, complications occurred in 28% of children and
mortality was 1.6%. The proportion of severe hospitalised
cases partly depends on the threshold for hospital admis-
sion and the availability of antimicrobials effective against
the bacteria causing enteric fever locally. Population-based
studies suggest that between 10% and 20% of cases are
admitted to hospital with the remainder managed in the
community.6,10 It is also possible that some children from
rural Cambodia, with inadequate access to healthcare facil-
ities, may  develop severe enteric fever with complications
and die without seeking medical attention.
We identiﬁed a very limited number of cases due to
serovar Paratyphi A. This is in contrast to other areas of
Asia where the proportion of enteric fever cases due to
serovar Paratyphi A is increasing.27 The factors that deter-
mine the relative proportion of serovar Typhi to Paratyphi
A in a community are not known, although of note, typhoid
vaccination is not widely used in this area. The number of
invasive infections with NTS was  also low, unlike in some
parts of sub-Saharan Africa where NTS are a common cause
of invasive bacterial infection in children below the age
of ﬁve years.28 Most of the children with an invasive NTS
infection in this study had previously recognized risk fac-
tors namely as a complication of severe diarrhoea in those
under 1 year of age or in those with HIV infection.28,29 It
is noteworthy that many of the NTS isolates were resis-
tant to commonly used antimicrobials, as seen in adjacent
countries.4The control of enteric fever requires the identiﬁcation
of locally important risk factors and includes improv-
ing access to clean water, uncontaminated food and the
availability of adequate sanitation.6 The detection and
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reatment of chronic carriers has been considered impor-
ant in controlling enteric fever in developed countries but
as not been employed in developing countries because of
he difﬁculty of detecting carriers. Although vaccination as
 public health tool is recommended in areas where the
urden of enteric fever is high and antimicrobial resistance
s a persistent problem, there are few places where it has
ctually been employed.30 Additional, prospective commu-
ity based studies of the epidemiology of enteric fever in
his area are required to enable a feasible control strategy
o be devised.
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